 | |
- close
- close
|
Marketwire
Oct 29
Comment
BEDFORD, MA -- (Marketwire) -- 10/29/09 -- Insulet Corporation (NASDAQ: PODD) today announced the pricing of its public offering of 6,000,000 shares of common stock at $10.25 per share. Insulet has granted the underwriters an option to purchase up to
Marketwire
Oct 28
Comment
BEDFORD, MA -- (Marketwire) -- 10/28/09 -- Insulet Corporation (NASDAQ: PODD) today announced that it will initiate, subject to market conditions, an underwritten public offering of 5,500,000 shares of common stock under an effective shelf
StreetInsider.com
Oct 27
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/William+Blair+Upgrades+Insulet+%28PODD%29+to+Outperform+/5046745.html for the full story.
StreetInsider.com
Oct 26
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Insulet+%28PODD%29+Reports+Large+Q3+Loss%3B+Raises+FY+Revenue+Outlook/5044915.html for the full story.
Marketwire
Oct 26
Comment
BEDFORD, MA -- (Marketwire) -- 10/26/09 -- Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the three and nine months ended
Marketwire
Oct 16
Comment
BEDFORD, MA -- (Marketwire) -- 10/16/09 -- Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, announced plans to release its financial results for the third quarter 2009
Marketwire
Sep 30
Comment
BEDFORD, MA -- (Marketwire) -- 09/30/09 -- Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, today announced it has been recognized by The Boston Business Journal as
Marketwire
Sep 28
Comment
BEDFORD, MA -- (Marketwire) -- 09/28/09 -- Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, today announced that it has amended its $60 million credit facility with
Marketwire
Sep 25
Comment
BEDFORD, MA -- (Marketwire) -- 09/25/09 -- Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, today announced the company will participate in the JMP Securities
newratings.com
Sep 16
Comment
NEW YORK, September 16 (newratings.com) - Analysts at Boenning & Scattergood initiate coverage of Insulet Corporation (ticker: PODD) with an "outperform" rating. The target price is set to $13.50. [more]
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
TOP CONTRIBUTORS
PODD AT A GLANCE
Per the CEO, Duane Desisto, they may have a pump company burried in a pod company. Meaning that other drugs may be delivered via the pod.
References
| ||||||
|
|
